유방 영상 진단 시장 : 제품, 기술, 장비 유형, 카테고리, 영상 모달리티, 용도, 최종사용자별 - 세계 예측(2025-2030년)

The Breast Imaging Market was valued at USD 5.40 billion in 2024 and is projected to grow to USD 5.83 billion in 2025, with a CAGR of 8.24%, reaching USD 8.69 billion by 2030.

Breast imaging continues to redefine the landscape of modern healthcare as it revolutionizes both diagnostic precision and patient management. In this expansive report, we deliver a detailed examination of the current market dynamics, emerging technologies, and innovative solutions that are propelling the industry forward. As advancements in imaging modalities and software solutions converge with improved system capabilities, stakeholders are presented with unprecedented opportunities for growth and enhanced patient outcomes.

In this summary, the overarching themes of transformative market shifts, intricate segmentation analyses, and global regional trends are unpacked in a clear, systematic manner. The narrative provides an introspective look into how cutting-edge software and systems are bolstering imaging processes, while a sharp focus on high-precision modalities such as digital mammography and molecular imaging underscores both the challenges and opportunities within the breast imaging space. The discussion spans across a diverse set of applications and end-users, ranging from diagnostic imaging centers to major hospitals, setting the stage for further detailed exploration.

This introduction serves as a prelude to the subsequent sections, which meticulously address the evolution of imaging strategies, the granular segmentation of market drivers, and regional as well as corporate insights that are shaping overall industry standards. Readers will encounter thoughtful analysis, responsible forecasting, and actionable recommendations that not only encapsulate the present scenario but also outline the trajectory for future innovations in breast imaging.

Transformative Shifts in Breast Imaging: Emerging Trends and Market Evolution

Technological innovation in breast imaging is catalyzing a paradigm shift, paving the way for transformative trends that reconceptualize the standard of care. Recent advancements have amalgamated improved imaging systems with sophisticated software integration, resulting in enhanced diagnostic accuracy and streamlined patient management procedures. The evolution is characterized by an increased reliance on real-time data processing, artificial intelligence algorithms integrated with imaging software, and refinements in hardware that yield superior resolution and faster processing speeds.

A deeper dive into the technological landscape reveals a trend where traditional two-dimensional imaging is rapidly being complemented, and in many cases, surpassed by three-dimensional and even four-dimensional imaging capabilities. This progression not only improves diagnostic precision but also empowers clinicians to engage in more informed decision-making at critical points in patient care. Additionally, there is a growing emphasis on minimization of radiation exposure coupled with maximized image quality, a balance achieved through iterative innovations in both digital and analog imaging categories.

Furthermore, this period of transformative change is marked by the convergence of diagnostic and therapeutic functions. For instance, systems that once operated solely as diagnostic tools are now evolving to offer guidance during interventional procedures, thereby bridging the gap between diagnosis and treatment. The infusion of cutting-edge software solutions that intelligently manage imaging data and assist in interpretation is another factor accelerating this transition. The result is a comprehensive, user-centric approach that redefines industry benchmarks and sets new standards for how breast imaging is performed across diverse healthcare environments.

Through continuous research and strategic investments in robust technology platforms, the breast imaging market is set to further expand its capabilities. The industry is witnessing an active shift from conventional practices towards more integrative, multi-dimensional imaging solutions which, in turn, enhance the overall healthcare delivery process.

Detailed Segmentation Insights Driving Market Growth

A comprehensive segmentation of the breast imaging market reveals multifaceted layers of analysis, each contributing to a clearer understanding of the market's intricate dynamics. The segmentation based on product differentiates the market by studying offerings in the fields of software and systems. The software dimension is further refined into imaging software and radiology software, each playing a pivotal role in modern diagnostic workflows. Complementarily, the systems segment is dissected to uncover the specialized applications within biopsy guidance systems, breast MRI systems, breast ultrasound systems, mammography systems, and tomosynthesis systems, collectively offering a panoramic view of imaging solutions.

When evaluated through the lens of technology, the market is segmented into areas of 2D, 3D, and 4D imaging, highlighting a transition from traditional imaging methods to advanced, multi-dimensional platforms that deliver higher accuracy and greater clinical utility. The equipment type segmentation further categorizes the offerings into integrated systems, mobile units, and standalone devices, thereby addressing diverse operational needs from fixed clinical settings to flexible point-of-care solutions. This segmentation accentuates the market's robust innovation and the adaptive nature of deployed solutions.

Moreover, the sector is segmented based on the underlying category which distinguishes between analog imaging and digital imaging, reflecting the historical evolution as well as the current thrust towards digital transformation in healthcare. A segmentation based on imaging modality provides insights into specialized techniques including breast tomosynthesis, contrast enhanced mammography, digital mammography, magnetic resonance imaging, molecular breast imaging, and ultrasound imaging. Each modality offers distinct clinical benefits and is chosen based on patient-specific needs and diagnostic criteria.

Further depth is achieved by examining the market through the prism of application, where the focus spans breast biopsy, diagnostic mammography, pre-surgical localization, and screening mammography. This analysis illustrates how dynamic use cases drive demand and innovation. Lastly, segmentation by end-user-encompassing ambulatory surgical centers, cancer research centers, diagnostic imaging centers, and hospitals-demonstrates the wide applicability of breast imaging technologies and underscores the importance of tailored solutions that address the needs of varied healthcare environments.

Based on Product, market is studied across Software and Systems. The Software is further studied across Imaging Software and Radiology Software. The Systems is further studied across Biopsy Guidance Systems, Breast MRI Systems, Breast Ultrasound Systems, Mammography Systems, and Tomosynthesis Systems.

Based on Technology, market is studied across 2D Imaging, 3D Imaging, and 4D Imaging.

Based on Equipment Type, market is studied across Integrated Systems, Mobile Units, and Standalone Devices.

Based on Category, market is studied across Analog Imaging and Digital Imaging.

Based on Imaging Modality, market is studied across Breast Tomosynthesis, Contrast Enhanced Mammography, Digital Mammography, Magnetic Resonance Imaging, Molecular Breast Imaging, and Ultrasound Imaging.

Based on Application, market is studied across Breast Biopsy, Diagnostic Mammography, Pre-Surgical Localization, and Screening Mammography.

Based on End-User, market is studied across Ambulatory Surgical Centers, Cancer Research Centers, Diagnostic Imaging Centers, and Hospitals.

Regional Insights: Navigating Global Trends in Breast Imaging

A geographic analysis of the breast imaging market emphasizes the significant role played by regional differences in shaping both market strategy and implementation. Emerging dynamics in the Americas underscore a mature landscape where innovation converges with a strong emphasis on patient-centric models. Here, technology adoption is at an all-time high, driven by high investments in digital imaging infrastructures and advanced diagnostic capabilities.

Across Europe, the Middle East, and Africa, market developments are witnessing a fusion of traditional imaging practices with modern technology. The integration of cutting-edge imaging solutions within this region is being accelerated by government initiatives, substantial research funding, and collaborative ventures between public and private healthcare entities. Meanwhile, these regions maintain a balanced approach by preserving elements of conventional diagnostic methodologies while progressively adopting innovative imaging systems that improve clinical outcomes.

In the Asia-Pacific region, the market is characterized by rapid growth fueled by both increasing healthcare expenditure and a rising awareness of early cancer detection. The region's trajectory is further enhanced by an upsurge in investments in healthcare infrastructure and a strong governmental backing for advancing technological capabilities. The combined prowess of these regions reinforces a vibrant global demand for breast imaging solutions, each contributing unique perspectives and strategic insights to the global market mosaic.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Market Leaders Shaping the Breast Imaging Industry

Key players in the breast imaging market have carved out prominent positions by consistently demonstrating a commitment to technological innovation and comprehensive service delivery. Industry leaders such as Agfa-Gevaert Group and Analogic Corporation have set benchmarks through their extensive portfolios that cover a broad array of imaging systems and software tools. Entities like Aurora Health, Inc. and Canon Inc. have further elevated market standards by integrating next-generation solutions that enhance both image quality and diagnostic speed.

Other significant contributors include Carestream Health Inc. and CMR Naviscan Corporation, which have been instrumental in driving advancements in imaging modalities and system integrations. Medical technology firms including Delphinus Medical Technologies, Inc. and EIZO Corporation continue to push boundaries in imaging clarity and workflow efficiency. Esteemed names such as Elekta AB and Esaote S.p.A. endorse sophisticated technological progress, exemplified by their investment in research and state-of-the-art imaging equipment.

Additional industry influencers such as FUJIFILM Holdings Corporation, GE HealthCare, and Hitachi Ltd. have redefined imaging standards by deploying innovative diagnostic solutions that balance precision with operational efficiency. Leaders like Hologic, Inc. and IMS Giotto S.p.A. complement these efforts through continuous product improvements and robust post-market support. International giants including Konica Minolta, Inc. and Koninklijke Philips N.V. play crucial roles in embedding electronics into medical workflows that make imaging both seamless and precise. Meanwhile, rapidly advancing companies such as Micrima Limited and Mindray Medical International Limited, supported by the technological acumen of Neusoft Medical Systems Co., Ltd., drive vital insights into modern diagnostic paradigms.

The market is further enriched by renowned organizations like Planmeca OY and Samsung Electronics Co., Ltd., partnered with specialists such as Sectra AB and Shanghai United Imaging Healthcare Co., LTD. The legacy of innovation is sustained by Shimadzu Corporation, Siemens Healthineers AG, Sonosdetect LLC, and Trivitron Healthcare Private Limited, all collaborating in an ecosystem that fosters constant technological breakthroughs and clinical advancements in breast imaging.

The report delves into recent significant developments in the Breast Imaging Market, highlighting leading vendors and their innovative profiles. These include Agfa-Gevaert Group, Analogic Corporation, Aurora Health, Inc., Canon Inc., Carestream Health Inc., CMR Naviscan Corporation, Delphinus Medical Technologies, Inc., EIZO Corporation, Elekta AB, Esaote S.p.A., FUJIFILM Holdings Corporation, GE HealthCare, Hitachi Ltd., Hologic, Inc., IMS Giotto S.p.A., Konica Minolta, Inc., Koninklijke Philips N.V., Micrima Limited, Mindray Medical International Limited, Neusoft Medical Systems Co., Ltd., Planmeca OY, Samsung Electronics Co., Ltd., Sectra AB, Shanghai United Imaging Healthcare Co., LTD, Shimadzu Corporation, Siemens Healthineers AG, Sonosdetect LLC, and Trivitron Healthcare Private Limited. Strategic Recommendations for Advancing in Breast Imaging

With the evolving dynamics of the breast imaging market, strategic recommendations for industry leaders are essential to navigate the complexities of technological integration and competitive differentiation. Stakeholders should prioritize continuous investment in research and development while embracing the dual imperatives of precision and efficiency. Embracing advanced imaging modalities not only enhances diagnostic accuracy but also contributes significantly to streamlined workflows and improved patient outcomes.

Leaders in the industry are advised to build robust partnerships with technology innovators and healthcare institutions. In doing so, they can harness unique insights to drive forward the adoption of integrated solutions that leverage both digital and analog imaging benefits. Investment in modernizing existing infrastructure with a focus on system interoperability is another key step, as it enables a seamless transition from legacy practices to cutting-edge imaging solutions. Furthermore, industry players should consider the strategic expansion of mobile and standalone imaging devices to cater to diverse clinical settings, ranging from high-volume diagnostic centers to specialized ambulatory surgical facilities.

To stay ahead in a competitive landscape, decision-makers should also explore avenues for strategic collaborations with academic and research institutions. Such partnerships can yield beneficial insights into upcoming imaging technologies and foster an environment primed for innovation. Moreover, a commitment to meeting regional regulatory requirements and adapting to local market nuances will prove critical in scaling operations on a global stage. By aligning long-term goals with evolving clinical needs and technological advancements, industry leaders can cement their position at the forefront of the breast imaging revolution.

Executive Summary Conclusion: Strategic Outlook and Future Directions

In conclusion, the breast imaging market is experiencing a transformative phase characterized by rapid technological advances and evolving diagnostic methodologies. The detailed segmentation analysis demonstrates the complexity and specificity of imaging solutions catering to diverse applications and end-users. The convergence of sophisticated imaging software with next-generation hardware is not only setting new clinical standards but also creating a fertile environment for innovation.

Global dynamics reveal that while mature markets in the Americas drive technological adoption, regions across Europe, the Middle East, Africa, and Asia-Pacific are rapidly embracing transformative strategies to meet both emerging and longstanding healthcare needs. Similarly, the competitive edge maintained by industry leaders through continuous innovation and customer-centric approaches emphasizes the importance of maintaining a forward-thinking strategy. Overall, a balanced approach that fuses technological innovation with strategic market positioning is imperative to sustaining long-term growth in the breast imaging field.

This report has thoroughly examined the nuances that define the current state of the market while also illuminating the pathways for future development. With an integrated view of both macroeconomic trends and micro-level segmentation insights, the comprehensive analysis underscores an optimistic outlook for the future of breast imaging.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence and awareness of breast cancer among women globally
    • 5.1.1.2. Rising adoption of personalized screening protocols and risk-based assessment strategies
    • 5.1.1.3. Improved reimbursement policies and supportive regulatory frameworks
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of advanced imaging equipment limits adoption in emerging markets
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of mobile breast imaging units for high-quality screening services
    • 5.1.3.2. Integration of AI-enabled software in breast imaging to enhance diagnostic accuracy
  • 5.1.4. Challenges
    • 5.1.4.1. Shortage of skilled radiologists and technicians specialized in breast imaging in emerging market
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Increasing adoption of breast imaging systems for enhanced diagnostic accuracy
  • 5.2.2. Technology: Adoption of 3D imaging technique for its extensive clinical validation
  • 5.2.3. Equipment Type: Incorporation of predictive analytics and advanced cloud connectivity in integrated systems
  • 5.2.4. Category: High preference for analog imaging in emerging markets and rural healthcare setups
  • 5.2.5. Imaging Modality: Rising preference for contrast-enhanced mammography for enhanced lesion visualization in diagnostics
  • 5.2.6. Application: Expanding application of breast imaging in breast cancer detection
  • 5.2.7. End-User: Surge in adoption of breast imaging in hospitals
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Breast Imaging Market, by Product

• 6.1. Introduction
• 6.2. Software
  • 6.2.1. Imaging Software
  • 6.2.2. Radiology Software
• 6.3. Systems
  • 6.3.1. Biopsy Guidance Systems
  • 6.3.2. Breast MRI Systems
  • 6.3.3. Breast Ultrasound Systems
  • 6.3.4. Mammography Systems
  • 6.3.5. Tomosynthesis Systems

7. Breast Imaging Market, by Technology

• 7.1. Introduction
• 7.2. 2D Imaging
• 7.3. 3D Imaging
• 7.4. 4D Imaging

8. Breast Imaging Market, by Equipment Type

• 8.1. Introduction
• 8.2. Integrated Systems
• 8.3. Mobile Units
• 8.4. Standalone Devices

9. Breast Imaging Market, by Category

• 9.1. Introduction
• 9.2. Analog Imaging
• 9.3. Digital Imaging

10. Breast Imaging Market, by Imaging Modality

• 10.1. Introduction
• 10.2. Breast Tomosynthesis
• 10.3. Contrast Enhanced Mammography
• 10.4. Digital Mammography
• 10.5. Magnetic Resonance Imaging
• 10.6. Molecular Breast Imaging
• 10.7. Ultrasound Imaging

11. Breast Imaging Market, by Application

• 11.1. Introduction
• 11.2. Breast Biopsy
• 11.3. Diagnostic Mammography
• 11.4. Pre-Surgical Localization
• 11.5. Screening Mammography

12. Breast Imaging Market, by End-User

• 12.1. Introduction
• 12.2. Ambulatory Surgical Centers
• 12.3. Cancer Research Centers
• 12.4. Diagnostic Imaging Centers
• 12.5. Hospitals

13. Americas Breast Imaging Market

• 13.1. Introduction
• 13.2. Argentina
• 13.3. Brazil
• 13.4. Canada
• 13.5. Mexico
• 13.6. United States

14. Asia-Pacific Breast Imaging Market

• 14.1. Introduction
• 14.2. Australia
• 14.3. China
• 14.4. India
• 14.5. Indonesia
• 14.6. Japan
• 14.7. Malaysia
• 14.8. Philippines
• 14.9. Singapore
• 14.10. South Korea
• 14.11. Taiwan
• 14.12. Thailand
• 14.13. Vietnam

15. Europe, Middle East & Africa Breast Imaging Market

• 15.1. Introduction
• 15.2. Denmark
• 15.3. Egypt
• 15.4. Finland
• 15.5. France
• 15.6. Germany
• 15.7. Israel
• 15.8. Italy
• 15.9. Netherlands
• 15.10. Nigeria
• 15.11. Norway
• 15.12. Poland
• 15.13. Qatar
• 15.14. Russia
• 15.15. Saudi Arabia
• 15.16. South Africa
• 15.17. Spain
• 15.18. Sweden
• 15.19. Switzerland
• 15.20. Turkey
• 15.21. United Arab Emirates
• 15.22. United Kingdom

16. Competitive Landscape

• 16.1. Market Share Analysis, 2024
• 16.2. FPNV Positioning Matrix, 2024
• 16.3. Competitive Scenario Analysis
  • 16.3.1. The TMIST trial leverages global research and innovative 2-D versus 3-D mammography screening
  • 16.3.2. Onsite Women's Health acquires The Katherine M. Cyran M.D. Breast Center to drive enhanced clinical care
  • 16.3.3. Hologic expands women's health portfolio with a USD 350 million acquisition of Gynesonics
  • 16.3.4. Solis Mammography expands into San Antonio with acquisition of Avestee Women's Imaging Centers
  • 16.3.5. GE HealthCare launches the Pristina VIA a mammography system
  • 16.3.6. Seno Medical's Imagio breast imaging system secures innovative technology contract with Vizient
  • 16.3.7. Berlin-based Vara leverages AI to enhance breast cancer screening accuracy
  • 16.3.8. University of Arizona researchers secure USD 3.3 million NIH grant to advance innovative 360-degree breast CT imaging
  • 16.3.9. Siemens Healthineers and FMP Healthcare invest in advanced 3D mammography and AI technology
  • 16.3.10. Yale research team leverages a USD 22 million ARPA-H award to develop cost-effective breast MRI
  • 16.3.11. Fujifilm India Healthcare and NM Medical unveil advanced full-field digital mammography skill lab
  • 16.3.12. Lunit acquired Volpara Health Technologies to integrate advanced breast screening software
  • 16.3.13. Lumisight gets FDA approval to enhance lumpectomy by enabling real-time fluorescence imaging
  • 16.3.14. DeepLook Medical secures USD 1.7 million seed funding from Connecticut Innovations
• 16.4. Strategy Analysis & Recommendation
  • 16.4.1. Koninklijke Philips N.V.
  • 16.4.2. Siemens Healthineers AG
  • 16.4.3. GE HealthCare
  • 16.4.4. Hologic, Inc.

Companies Mentioned

• 1. Agfa-Gevaert Group
• 2. Analogic Corporation
• 3. Aurora Health, Inc.
• 4. Canon Inc.
• 5. Carestream Health Inc.
• 6. CMR Naviscan Corporation
• 7. Delphinus Medical Technologies, Inc.
• 8. EIZO Corporation
• 9. Elekta AB
• 10. Esaote S.p.A.
• 11. FUJIFILM Holdings Corporation
• 12. GE HealthCare
• 13. Hitachi Ltd.
• 14. Hologic, Inc.
• 15. IMS Giotto S.p.A.
• 16. Konica Minolta, Inc.
• 17. Koninklijke Philips N.V.
• 18. Micrima Limited
• 19. Mindray Medical International Limited
• 20. Neusoft Medical Systems Co., Ltd.
• 21. Planmeca OY
• 22. Samsung Electronics Co., Ltd.
• 23. Sectra AB
• 24. Shanghai United Imaging Healthcare Co., LTD
• 25. Shimadzu Corporation
• 26. Siemens Healthineers AG
• 27. Sonosdetect LLC
• 28. Trivitron Healthcare Private Limited